Affiliations of authors: A. J. Swerdlow, Section of Epidemiology, Institute of Cancer Research, Sutton, U.K.; B. L. De Stavola, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, U.K.; B. Floderus, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; N. V. Holm, Department of Epidemiology, Institute of Public Health, University of Southern Denmark, and Department of Oncology and Radiotherapy, Odense University Hospital, Odense, Denmark; J. Kaprio, Department of Public Health, University of Helsinki, and Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, Finland; P. K. Verkasalo, Department of Public Health, University of Helsinki; T. Mack, Department of Preventive Medicine, University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles.
Correspondence to: Anthony J. Swerdlow, D.M., Section of Epidemiology, Institute of Cancer Research, Cotswold Rd., Sutton, Surrey SM2 5NG, U.K. (e-mail: a.swerdlow{at}icr.ac.uk).
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The comparison of exposures in affected versus unaffected twins provides a novel approach to address these issues, because ascertainment of risk factors at young ages might be better obtained by retrospective comparison between the two sisters than by comparison of a woman with her contemporaries in the general population. However, twins with breast cancer are not common and, to our knowledge, studies of twins with breast cancer have been conducted on a population basis only in Denmark, England and Wales, Finland, and Sweden. We therefore combined and analyzed data from these four previously unpublished studies to investigate breast cancer etiology.
![]() |
PATIENTS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In Denmark, a national register of all twins born in the country from 1870 through 1910 was compiled in 1954 from birth registers and was later expanded to include same-sex twins born from 1911 through 1930. A questionnaire was mailed to these twins (or to their relatives, if the twin was deceased) to determine zygosity and medical history. Twin pairs in which either member had died before the age of 6 years were excluded, as were pairs in which either twin had emigrated, irrespective of their date of emigration. All other twin pairs were considered eligible for the study. Zygosity was identified for over 92% of eligible twins. Breast cancers among the eligible twins were identified by their responses to questionnaires on their health status that were periodically sent to the twins themselves (the last questionnaire was sent in 1979), by examination of death certificates for twins who had died, and by matching of the twin register against the Danish Cancer Register for cancers incident from 1943 through 1979 (3). Only breast cancers with a verification of diagnosis from hospital records or other medical reports were included. Information on risk factors for breast cancer in twin pairs with at least one twin alive was obtained by interviews that were conducted from 1983 through 1986.
The Finnish twin cohort was created in 1974 by a computer search of the Central Population Register and consisted of all same-sex twins born before 1958 in Finland who were still alive on January 1, 1967. A questionnaire to determine zygosity was mailed to these twins in 1975, and breast cancers in female twin pairs were ascertained by matching the twins to the national cancer register for cancers incident from 1953 through 1983 (4). All breast cancer cases were histologically verified, and the diagnosis was checked by a breast cancer surgeon. The breast cancer case patients and their co-twins were interviewed in person during 1983 and 1984 about risk factors (5).
The earliest cohort of the Swedish Twin Registry was established in 1961 and consisted of all same-sex twin pairs who were born in Sweden from 1886 through 1925 in which both members of the pair were alive and had answered a questionnaire in 1961 that included questions on zygosity (6). The registry was expanded in 1971 by ascertaining in a similar way the zygosity of twins who were born from 1926 through 1967; a questionnaire was sent to those in this latter group of twins who were born from 1926 through 1958 (7). The study population for our study contained all female twins from the earliest Swedish cohort who were born from 1900 through 1925 and all female twins from the expanded cohort who were born from 1926 through 1958. Information on cancer incidence was obtained by linkage to the national cancer registry. Twins who were diagnosed with breast cancer from 1958 through 1982 were selected as potential case patients for the Swedish casecontrol study on breast cancer risk factors. Twin pairs were eligible for the study if the breast cancer diagnosis could be verified by medical records (which were scrutinized by an oncologist) and if at least one member of the pair was alive on January 1, 1983. Breast cancer patients and their co-twins were interviewed during personal visits to their homes from 1983 through 1985 or, in a few instances, asked in a mailed questionnaire for information on risk factors.
There is no national twin register in England or Wales; thus, twins with breast cancer were identified in a different way. National cancer registration records for breast cancers incident from 1971 through 1989 in women who were born in 1931 or later were cross-matched against national birth registers and against the National Health Service Central Register, in which twins are virtually always entered sequentially at birth. The breast cancer diagnoses were those accepted by the cancer registry. Information on zygosity and potential risk factors for breast cancer was ascertained from responses to questionnaires mailed to the twins and from telephone interviews conducted with the twins from 1994 through 1996 (8).
Statistical Analysis
For the combined analyses, the four datasets were checked for omissions and logical errors and then analyzed in parallel, using the same methods and categorization for each. Results for the four datasets analyzed separately were checked for heterogeneity. Because there was no statistically significant heterogeneity in any instance, the results presented are for the overall dataset for the four countries combined. The casecontrol data included breast cancers incident in women at a wide spectrum of ages. Our analysis is restricted to breast cancers incident in women aged less than 50 years, however, because this age group is the surrogate usually taken for premenopausal women and also because dichotomization of data at age 50 years has been found to modify anthropometric associations of breast cancer (9). (Although the questionnaires collected information on menopausal status, that information could not be used to categorize the co-twins for this analysis because the questions about menopausal status addressed to the interviewee about her co-twin referred to menopausal status at the time of interview, not at breast cancer diagnosis).
For twin pairs in which both women had been diagnosed with breast cancer, the following criteria were used to decide which woman would be considered the case patient and which would be considered the control subject. If the earlier date of incidence in the pair was before the period for which population-based ascertainment of breast cancer had been conducted in that country (such extra cancers were revealed by the questionnaires), the pair was excluded completely from analysis because the first cancer would not fulfill the study criteria to be a case and the second cancer would lack a control subject (i.e., an unaffected twin) at the time of cancer incidence. If the first breast cancer in the twin pair occurred during the period of incidence included in the study for that country, the twin with the cancer was considered the case patient and her co-twin, who at that time had not had breast cancer, was considered the control subject. Any subsequent breast cancer in the co-twin was not analyzed as a second case because, even if it occurred during the study incidence period, there was no unaffected twin then available who could be used as a control subject. (The shortest interval between cancer occurrences in twin pairs in which both members were diagnosed with breast cancer was 2 months).
The risk of breast cancer in relation to exposure variables was examined by calculating matched odds ratios (ORs) using conditional logistic regression (10), with 95% confidence intervals (CIs) based on a normal approximation. All statistical tests were two-sided. All analyses (except those involving reproductive variables) were adjusted for parity, which is a major known risk factor for breast cancer and a potential confounder. We did not adjust for age at first birth, because information about that factor was missing for a large number of subjects. Linear trends and heterogeneity of risks between countries and between subgroups by family history and zygosity were assessed by conditional likelihood ratio tests (10).
Although for some twin pairs, both sisters had replied to the questionnaires, for other twin pairs, only one sister had replied. We therefore had to decide whether to include these latter pairs in our analysis by using one sister's replies about both members of the pair. To make this decision, we assessed the reliability of cross-reports (reports by one twin about her co-twin) for each risk factor by cross-classifying the replies given by each subject about herself and her co-twin in pairs in which both of the twins had replied. For the risk factors presented in this article, we found that contradictory replies (e.g., each twin reporting that she was taller than the other at a particular age) were uncommon. Therefore, when both members of a pair had responded, we analyzed the data from both the case patient and her co-twin, after excluding the few pairs with contradictory replies; in pairs for which only one sister had responded, we used her responses about both members of the pair. In instances where both sisters had responded and one had reported a difference between the sisters for a comparative variable and the other had reported no difference between the sisters for the same variable, we used the response that reported a difference for the analysis. We used this approach because we believed that it was more likely that a response of "the same" for a variable such as height would include small differences, because it is unlikely that there would actually be no measurable difference. The analyses were repeated omitting pairs in which one twin reported a difference and the other reported no difference but, because the results were similar to those including such pairs and because the significant results remained so, these subset analyses have not been presented.
In addition to examining risks of breast cancer in the dataset overall, we also examined the risks in two subgroupings that we decided on a priori: monozygotic and dizygotic twins and familial and nonfamilial breast cancer cases. For the latter categorization, all case patients who were known to have had a first degree relative with breast cancer (including twin pairs in which both sisters had breast cancer) were classified as familial breast cancer cases, and the remainder were classified as nonfamilial breast cancer cases. We obtained data on cancer incidence in the co-twins from national cancer registries, which at the time of data extraction were considered complete through the end of 1986 for Denmark, through the end of 1993 for England and Wales, through the end of 1996 for Finland, and through the end of 1995 for Sweden. The information used about cancers in first-degree relatives other than co-twins was that collected during the interviews and from responses to the questionnaires.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
The results for weight adjusted for height were effectively analyses of obesity. We also analyzed risk of breast cancer in relation to obesity by a second method, that is, by analyzing risk in subcategories cross-classified by height and weightfor instance, taking as more obese than their co-twin women who were both heavier and shorter than their sister. The results from this analysis (data not shown) were similar to those of weight adjusted for height.
The risk of breast cancer was not statistically significantly associated with the relative size of the waist, hips, or breasts of the twins at age 20 years (Table 2). Women who had had a smaller waist-to-hip ratio than their co-twin (i.e., a smaller waist and same-sized or larger hips, or a same-sized waist and larger hips) had an increased risk of breast cancer compared with women who had a larger waist-to-hip ratio than their co-twin (OR = 1.79, 95% CI = 1.00 to 3.21 [data not shown]), but this result was based on only 55 twin pairs who reported one of these two options for waist-to-hip ratio and was of borderline statistical significance.
Women who reached menarche before their twin and those who menstruated regularly before their twin had statistically nonsignificantly increased risks of breast cancer. Women who developed breasts before their twin had a statistically significantly increased risk of breast cancer (P = .005; OR = 1.53, 95% CI = 1.14 to 2.06). These analyses were adjusted for parity and for height and weight at the same age (Table 2); the results were in the same direction, albeit less strongly, in the crude, unadjusted analyses. After further adjustment for age at menarche, the risk of breast cancer for women who developed breasts before their twin remained statistically significant (OR = 1.59, 95% CI = 1.17 to 2.16) (data not shown).
When we restricted the analyses in Table 2 to twin pairs in which both sisters replied to the questionnaires, the effect of weight adjusted for height at age 10 years was little changed by the restriction and remained statistically significant (OR = 1.60, 95% CI =1.09 to 2.35), the effect of height adjusted for weight at age 10 years became statistically significant (OR = 1.49, 95% CI = 1.01 to 2.19), and the effect of earlier breast development ceased to be statistically significant (OR = 1.13, 95% CI = 0.77 to 1.65).
When we repeated the analyses in Table 2 separately for monozygotic and dizygotic twins (shown for selected variables in Table 3
), the effects of height, weight, and puberty on breast cancer risk were almost always greater in the dizygotic twins than in the monozygotic twins. These findings were based on small numbers, however, and the only factors with a statistically significant effect on breast cancer risk in dizygotic twins were weight at age 10 years and earlier breast development (Table 3
).
|
The ORs of breast cancer associated with participation in sports at various ages were less than 1 but were not statistically significant (Table 4), and there was no consistent pattern of the effect of sports participation in data that were analyzed separately for monozygotic and dizygotic twins (data not shown). The effect on risk of participation in sports 5 years before breast cancer diagnosis was statistically significant for the women whose breast cancer was familial (OR = 0.23, 95% CI = 0.06 to 0.90) but not for those whose breast cancer was nonfamilial (OR = 0.81, 95% CI = 0.55 to 1.18) (data not shown). Because Bernstein et al. (12) found a differential effect of exercise on breast cancer risk according to whether women were parous or nulliparous, we examined separately the effect of adult exercise on breast cancer risk among parous and nulliparous women. The ORs in these groups were 0.71 (95% CI = 0.49 to 1.03) and 3.00 (95% CI = 0.27 to 33.72), respectively (data not shown).
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
It has so far proven extremely difficult, however, to test more directly the effects of childhood anthropometric variables on breast cancer risk. In several studies of premenopausal breast cancer, adult subjects have been asked about their height and weight (9,1623) and diet (17,18) in childhood or in adolescence. However, adults have difficulty recalling these variables, and the potential for misclassification is considerable, especially if a subject is asked to recall absolute values of the variables at a specific age. To our knowledge, only one study (11) has published results of analyses that used anthropometric data recorded during childhood or adolescence.
The use of twins, as in our study, provides unique advantages, as well as disadvantages, for addressing the relationship between breast cancer risk and childhood anthropometric variables. On the one hand, a twins study has strengths over a study that compares the subject with her peers in general (9,17,20,22), which is likely to be highly dependent on the subject's retrospective self-image, and over a study in which the subject is asked to recall absolute values for height and weight (16,18,19), which is likely to be highly inaccurate; instead, the use of comparative measures between the twins allows a comparison that is at least reasonably objective for the time to which the comparison applies and is internally validated (by questions to the co-twin). On the other hand, it is extraordinarily difficult to identify and interview a sufficient number of eligible subjects for a twins study; as a consequence, each of the four studies pooled in our article was itself of modest size and had unstable results on its own. For this reason, except for some data on parity for the twins from Denmark (24) and on mammographic patterns for the twins from Finland (5), results of the interviews from the four individual studies have not previously been published. A study that compares twins also has the disadvantage that it may overmatch for certain variables. Consequently, the apparent magnitude of an effect may be reduced, and the absence (or small size) of an effect for a factor in our study does not necessarily indicate that the factor has little or no relation to risk. Although the datasets from the four countries in our study differed in the years of cancer incidence, years of birth, and proportions of eligible subjects who were interviewed, we do not believe that these differences would have biased the results, because all analyses were twin pair-matched and, hence, matched on country and year of birth. Although there was no statistically significant heterogeneity between the country-specific effects, the power of the heterogeneity tests was low because of small numbers.
We found a statistically significantly decreased risk of breast cancer in relation to relative obesity at age 10 years, with an indication that the effect of obesity was greater at this age than at other ages. Our results on obesity are similar to those from the only study (11) that analyzed information on childhood height and weight that was recorded in childhood: in that study, in Hawaii, body mass index at ages 1014 years, but not at younger or older ages under 25 years, was statistically significantly inversely related to risk of breast cancer occurring in women younger than 50 years. Breast cancer risk in the Hawaiian study was lowest for subjects who were also overweight in young adulthood, but this was not so in our data.
In some (9,16,17,19,23) but not all (18,20,22) non-twin recall-based studies, reported adolescent weight or Quetelet's index (i.e., body mass index) has been found to be inversely associated with risk of premenopausal breast cancer. Because childhood obesity tends to be associated with earlier age at menarche, finding an inverse association between childhood obesity and breast cancer risk is not what would be expected from the well-established association between breast cancer risk and age at menarche; this finding implies that the effect of childhood obesity is not via any contribution to acceleration of puberty. The results of our analyses that adjusted for obesity later in life, suggest that the relationship between childhood obesity and risk was independent of, rather than a correlate of, the fairly well established inverse association (25) of adult obesity to premenopausal breast cancer risk.
Our data, and those from the Hawaiian study based on childhood height as reported by parents at the time (11), indicated that taller height at age 10 years was associated with breast cancer risk and that the effect may be greater in relation to height at this age than at other ages. In two non-twin, recall-based casecontrol studies that analyzed childhood height and breast cancer risk, an association between height and risk of subsequent breast cancer was found in one study (9) but not clearly in the other (22). Height might be a risk factor because it might be associated with mammary gland mass or because it is a marker of childhood nutrition. Our analysis of risk in relation to height at ages 10 and 20 years did not support the idea that an early growth spurt might be a risk factor for breast cancer (21). Height (but not body mass index or occurrence of menarche) in prepubertal girls is positively associated with serum insulin-like growth factor (IGF)-I concentration (26). A high serum level of IGF-I a few years before breast cancer diagnosis has been found to be associated with increased risk of premenopausal breast cancer (27), but no data exist on risk of breast cancer in relation to childhood IGF-I levels.
Another possible mechanism by which childhood growth might influence risk of breast cancer is by affecting mammary gland mass (28). Breast size, which is likely to be related to, although not an exact measure of, mammary gland mass, has been found to be associated with premenopausal breast cancer risk in some (2931) but not all (20,3032) studies. In our study, the results were in the direction of greater risk with greater breast size, but the risk increase was not statistically significant.
Young age at menarche has long been recognized as a risk factor for breast cancer, and the age at establishment of regular menstrual cycles has been found to be a risk factor independent of age at menarche, perhaps because regular menstruation might be associated with increased cumulative estrogen exposure (33). In our data, earlier age at the first menstrual period was slightly associated with risk, and age at first regular period more strongly associated with risk, but not statistically significantly in either case. There was, however, a statistically significant association that was independent of age at menarche between breast cancer risk and another pubertal variableage at breast developmentthat has been little investigated. To our knowledge, the only published study (9) to analyze the relationship between breast cancer risk and age at breast development was based on recall comparisons with contemporaries, and it showed results, after adjustment for age at menarche, that were in the same direction as ours. Most stages of breast development occur before menarche. Although reporting bias might have occurred for this variable, it is also possible that age at breast development may be an independent risk factor, because the growth and differentiation of the breast tissues that occur at pubertal development (34) might permanently alter the risk status of the breast; thus, at a given age, the number of years accumulated in this susceptible state would be greater for women whose breasts had developed earlier than for women whose breasts developed later.
We found that risk of breast cancer was increased for women with a low waist-to-hip ratio, compared with their co-twin, at age 20 years. Our data on this variable were indirect, however, and the comparison analyzed was between extreme categories of this variable. The only previously reported data on the relationship between waist-to-hip ratio and the risk of premenopausal breast cancer came from studies that reported waist-to-hip ratios measured at the time of the study interviews; those results were in the same direction as ours in one study (20) but not in two other studies (29,35). A low waist-to-hip ratio could be relevant to breast cancer risk because in premenopausal women such a ratio is associated with increased estrogenic, compared with androgenic, activity (36).
Studies have reported that physical exercise after menarche is associated with a reduced risk of premenopausal breast cancer, perhaps by reducing a woman's cumulative exposure to cyclic estrogens and progesterone (12,37). We found ORs in relation to sporting activity that were in this direction but were not statistically significant. The OR in our data for breast cancer in relation to adult exercise was more greatly reduced in women with familial breast cancer than in those with nonfamilial breast cancer, a comparison that, to our knowledge, has not previously been examined in premenopausal women; the OR in our data for breast cancer in relation to adult exercise was also lower among parous women than among nulliparous women, adding to previous evidence of the same effect (12). Very high levels of exercise can delay menarche, and hence potentially affect breast cancer risk, but our data did not suggest that exercise at premenarcheal ages was important to risk in a study group that was not selected for its high exercise levels.
The increased risk of breast cancer in nulliparous women is well established, but it is less clear whether the effects of nulliparity apply to women with a family history of breast cancer as well as to women without such a history. In our data, parity was associated with a decreased risk of breast cancer of similar magnitude in both of these subgroups as well as within both monozygotic and dizygotic twin pairs. The use of twins in our study design has the strength that, unlike conventional recall-based casecontrol studies, differential completeness of reporting of family history between cases and controls (38) will not have potential to bias the results, because the same family history is used for each member of the twin pair. Reports by breast cancer patients of breast cancer in their first-degree relatives have been found to be 99% accurate (39). The only other study of breast cancer risk in relation to family history and parity in women who were premenopausal or at premenopausal ages found, as we did, that family history did not modify the effect of parity (40). In studies that analyzed a mixture of pre- and postmenopausal breast cancers, results have variedfrom no modification of the effect of parity by family history (41) to an absent effect of nulliparity or even a reduced risk with nulliparity in women with a family history of breast cancer (4244). In young women who carry mutations in the BRCA1 or BRCA2 genes, nulliparity has been found to be associated with a decreased risk of breast cancer (45); however, the great majority of familial cases of breast cancer that occur at premenopausal ages do not have these mutations (46).
In our study, the effects of childhood height, weight, and breast development on breast cancer risk appeared to apply within dizygotic but not within monozygotic twin pairs; there are no previous data on this relationship. Monozygotic twins, because they are genetically identical, would be expected to show no effect for factors whose variability is of genetic origin. Monozygotic twins might also show less effect than dizygotic twins, however, for prenatal factors [because monozygotic twins usually have a shared chorion, with communication between the fetal circulations (47), whereas dizygotic twins have a dichorionic placenta] and for childhood factors, because monozygotic twins may behave and be treated more similarly in childhood than dizygotic twins.
The effects of anthropometric variables at age 10 years on risk were apparent in nonfamilial but not in familial cases of breast cancer. The only other comparable analysis we could find was from a small (50 cases) recall-based casecontrol study of premenopausal bilateral breast cancer, which also indicated that weight and obesity at menarche were associated with risk only in nonfamilial cases (19). The relationship between age at breast development and risk observed in our data was seen in both familial and nonfamilial cases; this familial/nonfamilial subdivision does not appear to have been examined previously.
Overall, our results provide a unique type of evidence that suggests that childhood growth before puberty may be an important contributor to risk of premenopausal breast cancer.
![]() |
NOTES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We thank Gudrun Hauge in Denmark; Maureen Swanwick in England; Elsa Glade, Ulla Kulmala-Gråhn, and Eila Voipio in Finland; and Bodil Johanson, Åsa Johansson, and Ann-Marie Tell in Sweden, who carried out the data collection from the twins. We also thank the Office for National Statistics, S. Armitage, A. Casely-Hayford, Y. Forshaw, H. Lipsey, N. Maconochie, P. Mangtani, H. Nguyen, A. Reid, and P. Riach for identifying the twins in England and Wales; Kauko Heikkilä in Finland for computer work, and Dr. Arto Alanko, at that time with the Department of Surgery, Helsinki University Central Hospital; and in Sweden, Kristina Bildt for study administration, Lottie Barlow for computer work, and Drs. Arne Wallgren and Lars-Erik Holm, at that time with the Department of Oncology-Pathology, Karolinksa Institutet, for scrutinizing the hospital records.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1 Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet 1990;335:93940.[Medline]
2 de Waard F, Trichopoulos D. A unifying concept of the aetiology of breast cancer. Int J Cancer 1988;41:6669.[Medline]
3 Holm NV, Hauge M, Jensen OM. Studies of cancer aetiology in a complete twin population: breast cancer, colorectal cancer and leukaemia. Cancer Surv 1982;1:1732.
4 Kaprio J, Teppo L, Koskenvuo M, Pukkala E. Cancer in adult same-sexed twins: a historical cohort study. Prog Clin Biol Res 1981;69(Pt C):21723.[Medline]
5 Kaprio J, Alanko A, Kivisaari L, Standertskjold-Nordenstam CG. Mammographic patterns in twin pairs discordant for breast cancer. Br J Radiol 1987;60:45962.[Abstract]
6 Cederlof R, Friberg L, Lundman T. The interactions of smoking, environment and heredity and their implications for disease etiology. A report of epidemiological studies on the Swedish twin registries. Acta Med Scand Suppl 1977;612:1128.[Medline]
7 Medlund P, Cederlof R, Floderus-Myrhed B, Friberg L, Sorensen S. A new Swedish Twin Registry: containing environmental and medical base line data from about 14,000 same-sexed pairs born 19261958. Acta Med Scand Suppl 1976;600:1111.
8 Swerdlow AJ, De Stavola BL, Swanwick MA, Maconochie NE. Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 1997;350:17238.[Medline]
9 Brinton LA, Swanson CA. Height and weight at various ages and risk of breast cancer. Ann Epidemiol 1992;2:597609.[Medline]
10 Clayton D, Hills M. Statistical models in epidemiology. Oxford (U.K.): Oxford University Press; 1993. p. 23748.
11 Le Marchand L, Kolonel LN, Earle ME, Mi MP. Body size at different periods of life and breast cancer risk. Am J Epidemiol 1988;128:13752.[Abstract]
12 Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst 1994;86:14038.[Abstract]
13 Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:9636.[Medline]
14 Vatten LJ, Kvinnsland S. Body height and risk of breast cancer. A prospective study of 23,831 Norwegian women. Br J Cancer 1990;61:8815.[Medline]
15 Tretli S, Gaard M. Lifestyle changes during adolescence and risk of breast cancer: an ecologic study of the effect of World War II in Norway. Cancer Causes Control 1996;7:50712.[Medline]
16 Choi NW, Howe GR, Miller AB, Matthews V, Morgan RW, Munan L, et al. An epidemiologic study of breast cancer. Am J Epidemiol 1978;107:51021.[Abstract]
17 Hislop TG, Coldman AJ, Elwood JM, Brauer G, Kan L. Childhood and recent eating patterns and risk of breast cancer. Cancer Detect Prev 1986;9:4758.[Medline]
18 Pryor M, Slattery ML, Robison LM, Egger M. Adolescent diet and breast cancer in Utah. Cancer Res 1989;49:21617.[Abstract]
19 Ursin G, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Early adult body weight, body mass index, and premenopausal bilateral breast cancer: data from a case-control study. Breast Cancer Res Treat 1995;33:7582.[Medline]
20 Franceschi S, Favero A, La Vecchia C, Baron AE, Negri E, Dal Maso L, et al. Body size indices and breast cancer risk before and after menopause. Int J Cancer 1996;67:1816.[Medline]
21 Li CI, Malone KE, White E, Daling JR. Age when maximum height is reached as a risk factor for breast cancer among young U.S. women. Epidemiology 1997;8:55965.[Medline]
22 Coates RJ, Uhler RJ, Hall HI, Potischman N, Brinton LA, Ballard-Barbash R, et al. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer 1999;81:16774.[Medline]
23 Berkey CS, Frazier AL, Gardner JD, Colditz GA. Adolescence and breast carcinoma risk. Cancer 1999;85:24009.[Medline]
24 Holm NV, Hauge M, Harvald B. Etiologic factors of breast cancer elucidated by a study of unselected twins. J Natl Cancer Inst 1980;65:28598.[Medline]
25 Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995;6:13741.[Medline]
26 Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:74452.[Abstract]
27 Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:13936.[Medline]
28 Trichopoulos D, Lipman RD. Mammary gland mass and breast cancer risk. Epidemiology 1992;3:5236.[Medline]
29 Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control 1995;6:4318.[Medline]
30 Swanson CA, Coates RJ, Schoenberg JB, Malone KE, Gammon MD, Stanford JL, et al. Body size and breast cancer risk among women under age 45 years. Am J Epidemiol 1996;143:698706.[Abstract]
31 Boice JD Jr, Friis S, McLaughlin JK, Mellemkjaer L, Blot WJ, Fraumeni JF Jr, et al. Cancer following breast reduction surgery in Denmark. Cancer Causes Control 1997;8:2538.[Medline]
32 Hsieh CC, Trichopoulos D. Breast size, handedness and breast cancer risk. Eur J Cancer 1991;27:1315.[Medline]
33 Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 2nd ed. New York (NY): Oxford University Press; 1996; p. 102239.
34 Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994;3:35364.[Abstract]
35 Bruning PF, Bonfrer JM, Hart AA, van Noord PA, van der Hoeven H, Collette HJ, et al. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 1992;51:149.[Medline]
36 Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983;57:30410.[Abstract]
37 Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:126975.
38 Floderus B, Barlow L, Mack TM. Recall bias in subjective reports of familial cancer. Epidemiology 1990;1:31821.[Medline]
39 Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994;3:3217.[Medline]
40 Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, et al. Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev 1998;7:35964.[Abstract]
41 McCredie M, Paul C, Skegg DC, Williams S. Family history and risk of breast cancer in New Zealand. Int J Cancer 1997;73:5037.[Medline]
42 Colditz GA, Rosner BA, Speizer FE. For the Nurses' Health Study Research Group. Risk factors for breast cancer according to family history of breast cancer. J Natl Cancer Inst 1996;88:36571.
43 Parazzini F, La Vecchia C, Negri E, Franceschi S, Bocciolone L. Menstrual and reproductive factors and breast cancer in women with family history of the disease. Int J Cancer 1992;51:67781.[Medline]
44 Bain C, Speizer FE, Rosner B, Belanger C, Hennekens CH. Family history of breast cancer as a risk indicator for the disease. Am J Epidemiol 1980;111:3018.[Abstract]
45 Jernstrom H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 1999;354:184650.[Medline]
46 Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999;91:9439.
47 Benirschke K, Kim CK. Multiple pregnancy. 1. N Engl J Med 1973;288:127684.[Medline]
Manuscript received November 23, 2001; revised June 12, 2002; accepted June 24, 2002.
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
||||
|
Oxford University Press Privacy Policy and Legal Statement |